chr4-73104747-C-T

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2

The NM_032217.5(ANKRD17):​c.4402-2200G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0272 in 140,244 control chromosomes in the GnomAD database, including 74 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.027 ( 74 hom., cov: 31)

Consequence

ANKRD17
NM_032217.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.77
Variant links:
Genes affected
ANKRD17 (HGNC:23575): (ankyrin repeat domain 17) The protein encoded by this gene belongs to the family of ankyrin repeat-containing proteins, and contains two distinct arrays of ankyrin repeats in its amino-terminal region, one with 15 ankyrin repeats, and the other with 10 ankyrin repeats. It also contains a nuclear export signal, nuclear localization signal, and a cyclin-binding RXL motif. Localization of this protein to the nucleus has been shown experimentally, and interactions between this protein and cyclin-dependent kinase 2 have been observed. It has been suggested that this protein plays a role in both DNA replication and in both anti-viral and anti-bacterial innate immune pathways. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0272 (3818/140244) while in subpopulation AFR AF= 0.0411 (1523/37040). AF 95% confidence interval is 0.0394. There are 74 homozygotes in gnomad4. There are 1853 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High AC in GnomAd4 at 3818 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ANKRD17NM_032217.5 linkuse as main transcriptc.4402-2200G>A intron_variant ENST00000358602.9 NP_115593.3
LOC124900713XR_007058138.1 linkuse as main transcriptn.89+314C>T intron_variant, non_coding_transcript_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ANKRD17ENST00000358602.9 linkuse as main transcriptc.4402-2200G>A intron_variant 5 NM_032217.5 ENSP00000351416 O75179-1

Frequencies

GnomAD3 genomes
AF:
0.0272
AC:
3812
AN:
140152
Hom.:
74
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0411
Gnomad AMI
AF:
0.0324
Gnomad AMR
AF:
0.0247
Gnomad ASJ
AF:
0.0425
Gnomad EAS
AF:
0.00236
Gnomad SAS
AF:
0.0287
Gnomad FIN
AF:
0.0210
Gnomad MID
AF:
0.0235
Gnomad NFE
AF:
0.0215
Gnomad OTH
AF:
0.0286
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0272
AC:
3818
AN:
140244
Hom.:
74
Cov.:
31
AF XY:
0.0274
AC XY:
1853
AN XY:
67686
show subpopulations
Gnomad4 AFR
AF:
0.0411
Gnomad4 AMR
AF:
0.0247
Gnomad4 ASJ
AF:
0.0425
Gnomad4 EAS
AF:
0.00237
Gnomad4 SAS
AF:
0.0290
Gnomad4 FIN
AF:
0.0210
Gnomad4 NFE
AF:
0.0215
Gnomad4 OTH
AF:
0.0283
Alfa
AF:
0.0238
Hom.:
20
Bravo
AF:
0.0263
Asia WGS
AF:
0.0320
AC:
111
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
CADD
Benign
0.20
DANN
Benign
0.25

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs6818964; hg19: chr4-73970464; API